Related references
Note: Only part of the references are listed.Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical Platform
Jeffrey J. Talbot et al.
AAPS JOURNAL (2015)
Proposal for a harmonized descriptive analyte nomenclature for quantitative large-molecule bioanalysis
Julia Heinrich et al.
BIOANALYSIS (2015)
In Vitro and In Vivo Activity of the Low-Immunogenic Antimesothelin Immunotoxin RG7787 in Pancreatic Cancer
Kevin Hollevoet et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers
Christine Alewine et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrations
Roland F. Staack et al.
BIOANALYSIS (2014)
Can LC-MS/MS and ligand-binding assays live in harmony for large-molecule bioanalysis?
Apollon Papadimitriou et al.
BIOANALYSIS (2014)
Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation
Marian Kelley et al.
AAPS JOURNAL (2013)
Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples
Kay Stubenrauch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Narendra Chirmule et al.
AAPS JOURNAL (2012)
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantification
Roland F. Staack et al.
BIOANALYSIS (2012)
Bioanalytical Approaches to Quantify Total and Free Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
Jean W. Lee et al.
AAPS JOURNAL (2011)
PK-PD modeling of protein drugs: implications in assay development
Lorin K. Roskos et al.
BIOANALYSIS (2011)
Application and interpretation of free and total drug measurements in the development of biologics
Ago B. Ahene
BIOANALYSIS (2011)
Therapeutic monoclonal antibody concentration monitoring: free or total?
Bing Kuang et al.
BIOANALYSIS (2010)
Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations
Douglas M. Fast et al.
AAPS Journal (2009)
Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates
Kay Stubenrauch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Rafael Ponce et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry
Olivier Heudi et al.
ANALYTICAL CHEMISTRY (2008)
Key elements of bioanalytical method validation for macromolecules
Marian Kelley et al.
AAPS JOURNAL (2007)
Share Paper
